Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Emerging azole antifungals.

Anne Chen1, Jack D Sobel

  • 1Wayne State University, Detroit Medical Center, 3990 Harper Street, 5 Hudson, Detroit, MI 48201, USA.

Expert Opinion on Emerging Drugs
|March 11, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phenotypic and genotypic analysis of <i>Candida albicans</i> vaginal isolates reveals that <i>ECE1</i> expression underpins pathogenicity.

Infection and immunity·2026
Same author

Antibody Therapy-Associated Artifactual Light Chain Restriction in Flow Cytometry Beyond the Setting of Plasma Cell Neoplasm.

International journal of laboratory hematology·2026
Same author

Greater hypoxic burden predicts weaker coordination between brain pulsation and CSF flow on 7T MRI independent of non-hypoxic arousals: Implications for glymphatic activity.

bioRxiv : the preprint server for biology·2026
Same author

Sexual transmission of vaginal pathogens and male partner treatment: is it time to consider vulvovaginal candidiasis?

Sexually transmitted infections·2026
Same author

State-of-the-Art Review: Managing Vulvovaginal Candidiasis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Performance of an electroencephalography-measuring headband or actigraphy compared with polysomnography in older adults with sleep disturbances.

Sleep·2026

New triazole antifungals show broad-spectrum activity against resistant fungal infections, offering hope for treating immunocompromised patients. This review covers emerging azole antifungals in development and their future potential.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Pharmacology

Background:

  • Fungal infections are a growing global health concern, particularly in immunocompromised individuals.
  • Existing antifungal treatments face challenges due to increasing drug resistance and a rising high-risk population.
  • There is a critical need for novel, safe, and effective therapies for systemic fungal diseases.

Purpose of the Study:

  • To review emerging azole antifungal agents.
  • To discuss their clinical development and spectrum of activity.
  • To evaluate their future prospects in combating fungal infections.

Main Methods:

  • Literature review of clinical investigations and development phases of new azole antifungals.
  • Analysis of reported activity against resistant fungal pathogens.

Related Experiment Videos

  • Synthesis of current data on voriconazole, posaconazole, ravuconazole, and albaconazole.

    • Main Results:

    • A new generation of triazoles (voriconazole, posaconazole, ravuconazole, albaconazole) is in clinical development.
    • These agents exhibit broad-spectrum activity, including against previously resistant fungal strains.
    • They represent promising therapeutic options for systemic fungal infections.

    Conclusions:

    • Emerging azole antifungals offer a vital advancement in treating difficult fungal infections.
    • These drugs are crucial for managing infections in the immunocompromised population.
    • Continued research and development are essential to expand the arsenal against fungal diseases.